In this final analysis , @ patients ( @ % , @ % CI @-@ ) in the carboplatin group achieved a pathological complete response , compared with @ patients ( @ % , @-@ ) without carboplatin ( odds ratio @ , @ % CI @-@ ; p = @ ) .